Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4312 results

Sort By:

Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2

Study ID: NCT06783504
Start Date: 2026-02-10
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION

Sham percutaneous electrical nerve field stimulation

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

Taurine Supplementation in Long COVID

Study ID: NCT06721949
Start Date: 2025-10
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

Taurine

Placebo

Sponsor

University of Alberta

Source: clinicaltrials.gov

Share:
Add to list

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

Study ID: NCT06585358
Start Date: 2025-10-01
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

MIPD

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list

Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss

Study ID: NCT06735859
Start Date: 2025-11
End Date: 2027-11-19
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

Comparison of eating windows intervention

Sponsor

Federal University of São Paulo

Source: clinicaltrials.gov

Share:
Add to list

Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB

Study ID: NCT06205589
Start Date: 2025-10-15
End Date: 2029-10-13
Study Type

Interventional

Study Phase

Phase2

No. of Participants

1500

Intervention / Treatment

ID93 + GLA-SE VACCINE

Placebo vaccine

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Source: clinicaltrials.gov

Share:
Add to list

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Study ID: NCT06501989
Start Date: 2025-12-15
End Date: 2026-08-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Biweekly 5-FLUOROURACIL (5-FU)

Biweekly Modified FOLFOX6

Biweekly FOLFIRI

rolling

Sponsor

Inova Health Care Services

Source: clinicaltrials.gov

Share:
Add to list

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Study ID: NCT07075510
Start Date: 2025-10-01
End Date: 2032-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Daratumumab Injection

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Study ID: NCT06817720
Start Date: 2026-07-30
End Date: 2027-03-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

fluffy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Effects of taVNS on Fibromyalgia Pain

Study ID: NCT06193317
Start Date: 2026-06-01
End Date: 2029-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

152

Intervention / Treatment

Transauricular vagus nerve stimulation (taVNS)

Sponsor

Spaulding Rehabilitation Hospital

Source: clinicaltrials.gov

Share:
Add to list

Deciphering the Genetic Architecture of Autoimmune Diseases

Study ID: NCT06948110
Start Date: 2025-09-30
End Date: 2030-04-22
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

National Human Genome Research Institute (NHGRI)

Source: clinicaltrials.gov

Share:
Add to list